Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Vestal Point Capital, LP's stake in Dianthus Therapeutics, Inc. fell to 3.00% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Vestal Point Capital, LP's stake in Dianthus Therapeutics, Inc. fell to 3.00%, 1,180,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 3.00%
- Shares
- 1,180,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 3.00% | 1,180,000 |
| Ryan Wilder | 3.00% | 1,180,000 |
Source
Related
- Dianthus Therapeutics, Inc.
- Vestal Point Capital, LP
- Dianthus Therapeutics, Inc. shareholders
- Schedule 13G/A · Vestal Point Capital, LP · Aug 14, 2025
- Schedule 13G · Vestal Point Capital, LP · May 15, 2025
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026